Silexion Therapeutics priced 3.85M shares and warrants at $0.65 each to raise approximately $2.5M.
Silexion Therapeutics priced a public offering of 3.85 million ordinary shares or equivalents, alongside Series E warrants for the same number of shares, at a combined price of $0.65 per share and warrant. The move is expected to raise about $2.5 million for the company.
The offering includes both shares and warrants, structured to provide investors with additional upside potential. No prior pricing or consensus estimates were disclosed for comparison.
Details on immediate market reaction or trading impact were not provided in the release.